Latest News

Analyst says he’s thrown in the towel on Novo Nordisk after latest setback

February 24, 2026 at 09:12 AM
By MarketWatch
Analyst says he’s thrown in the towel on Novo Nordisk after latest setback
Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years.

💡Analysis & Context

Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years. Monitor developments in Analyst for further updates.

📋 Quick Summary

Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to dow

Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years.
Share:

Original Source:

Read full article at source

Help us improve this article. Share your feedback and suggestions.

Related Articles

Dry Day: Liquor shops to remain closed on Holi, Muharram, Gandhi Jayanti, Maharashtra government clarifies

Dry Day: Liquor shops to remain closed on Holi, Muharram, Gandhi Jayanti, Maharashtra government clarifies

Earlier, it was reported that the Maharashtra government had allowed licensed liquor retail outlets to sell alcohol on these days. The decision, the reports claim, was taken to curb the rise of unauthorized and counterfeit liquor sales on dry days.

Feb 24, 2026
Old-Economy Stocks Are Looking Pretty Good Right About Now

Old-Economy Stocks Are Looking Pretty Good Right About Now

A basket of capital-intensive stocks is rallying as investors flee AI disruption.

Feb 24, 2026
📰

Home Depot beats Wall Street’s expectations, even as sales decline

Home Depot beat fourth-quarter earnings expectations after missing estimates the prior three quarters.

Feb 24, 2026
Tata Defers Vote on Chairman’s New Term, Signaling Power Tussle

Tata Defers Vote on Chairman’s New Term, Signaling Power Tussle

The board of Tata Sons Pvt. deferred a decision on granting a third term to Chairman Natarajan Chandrasekaran, people familiar said, in the latest sign that another leadership tussle could be brewing at India’s oldest conglomerate.

Feb 24, 2026
America’s Ube Obsession Is Straining Supplies

America’s Ube Obsession Is Straining Supplies

Ube has officially gone viral. Purple lattes, cheesecakes and pancakes are increasingly cropping up on dessert menus, but as a result, supplies are tightening. Ilena Peng has more. (Source: Bloomberg)

Feb 24, 2026
📰

Intel partners with AI chip startup SambaNova after acquisition talks reportedly failed

Intel CEO Lip-Bu Tan first invested in SambaNova in 2017. Now the chipmaker he runs is putting more capital behind the startup.

Feb 24, 2026

Cookie Consent

We use cookies to enhance your browsing experience, analyze site traffic, and serve personalized ads. By clicking "Accept", you consent to our use of cookies. You can learn more about our cookie practices in our Privacy Policy.